Nasdaq
$63.97▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $36.84BShares out 5.800M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
19- 10.5After-hours26.10.06 06:124Ownership#●●●
Royalty Pharma plc
Insider Marshall Urist of Royalty Pharma plc reported a change in beneficial ownership of securities on October 5, 2026. This filing serves as a Form 4 statement regarding the insider's equity position.…more
$63.97+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.5After-hours26.10.06 05:02144Ownership
Royalty Pharma plc
Marshall Urist, an insider at Royalty Pharma plc, has filed an SEC Form 144 to report a plan to sell company shares. This filing serves as a formal notification of the insider's intent to dispose of their holdings.…more
$63.97+0.00%vs prev closeView filingShare - 9.30After-hours26.10.01 05:334Ownership
Royalty Pharma plc
Bonnie L. Bassler, a director of Royalty Pharma plc, has filed a Form 4 report regarding changes in beneficial ownership of company securities as of September 30, 2026. This filing serves as the official disclosure of the insider transaction.…more
$63.97+0.00%vs prev closeView filingShare
18 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.16Pre-market26.10.16 21:00#●●●
Royalty Pharma Declares Q4 2026 Dividend of $0.235 Per Share
Royalty Pharma has announced a cash dividend of $0.235 per Class A ordinary share for the fourth quarter of 2026. The dividend will be paid on December 10, 2026, to shareholders of record as of November 13, 2026.…more
$63.97+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.9Pre-market26.10.09 21:50
●●●●●●●● ●●●●● ●●●●●●
Royalty Pharma announced that it will release its third quarter 2026 financial results before the U.S. market opens on November 4, 2026. The company will host a conference call and webcast to discuss the results with investors.…more
$63.97+0.00%vs prev close - 9.15After-hours26.09.16 05:35
●●●●●●●● ●●●●● ●●●●●●
Royalty Pharma has donated $7.5 million to support the Therapy Acceleration Program (TAP) aimed at advancing blood cancer treatments. This contribution serves as a philanthropic initiative and does not represent a direct financial catalyst for the company's stock.…more
$63.97+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report